Abstracto

Coronavirus vaccine-associated lung immunopathology-what is the centrality.

David Corry

As an extended number of coronavirus antibodies enter human clinical trials, in expansion to understanding their adequacy in avoiding extreme SARS-CoV-2-related infection, a key result that will be accepting outsized examination will be whether these immunizations contribute to lung immunopathology upon common viral contamination.